Showing 981-990 of 1559 results for "".
When to Refer to a Neuro-Optometrist
https://modernod.com/topics/neuro-optometry/when-to-refer-to-a-neuro-optometrist/37989/Chances are, many of your patients could benefit.Sharpen Your AMD Diagnostic Skills
https://modernod.com/topics/retina/sharpen-your-amd-diagnostic-skills/37980/Know how to spot early AMD, and have a plan of action.Finding Synergies Between Vision and Medical Insurance
https://modernod.com/topics/business/finding-synergies-between-vision-and-medical-insurance/37977/Unlock the paths to subsequent patient encounters by coordinating benefits.Myths and Misconceptions in Dry Eye Disease Management
https://modernod.com/topics/ocular-surface/myths-and-misconceptions-in-dry-eye-disease-management/37891/Clearing the air.Improving Patient Flow
https://modernod.com/topics/business/improving-patient-flow/39187/Strengthen the efficiency of your practice by avoiding patient bottlenecks.Involving Patients in the Care of Their AMD
https://modernod.com/topics/retina/involving-patients-in-the-care-of-their-amd/39175/A typical week in the life of this retina specialist shows that the future of home monitoring is now.Why Health Equity Matters
https://modernod.com/topics/business/why-health-equity-matters/38508/Access to quality health care is still not a guarantee for all, but organizations are making efforts to improve population health, especially among minority groups.A Review of Pharmacologic Treatments for Presbyopia
https://modernod.com/topics/presbyopia/a-review-of-pharmacologic-treatments-for-presbyopia/39027/With several therapies on the market, understanding their differences is the key to optimizing clinical decision making.2024 in Review: FDA Approvals and Product Launches
https://modernod.com/mod-issues/2025-jan-feb/2024-in-review-fda-approvals-and-product-launches/38933/An overview of new optometric medications and technologies to know about.Side Effects of Glaucoma Medications
https://modernod.com/mod-issues/2021-jan-feb/side-effects-of-glaucoma-medications/39117/Providers must be aware of the common and uncommon side effects associated with each agent and class of medication.